Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy (Q46774737): Preview

Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy (Q46774737)
scientific article

Language:

Current Data About Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy

(P31)

(Q13442814)

(P248)
(P698)	18246224
(P813)	Monday, December 25, 2017
(P854)	http://europepmc.org/abstract/MED/18246224

(P304)

185-192

(P248)
(P698)	18246224
(P813)	Monday, December 25, 2017
(P854)	http://europepmc.org/abstract/MED/18246224

(P433)

(P248)
(P698)	18246224
(P813)	Monday, December 25, 2017
(P854)	http://europepmc.org/abstract/MED/18246224

(P478)

(P248)
(P698)	18246224
(P813)	Monday, December 25, 2017
(P854)	http://europepmc.org/abstract/MED/18246224

(P577)

Friday, February 1, 2008

(P248)
(P698)	18246224
(P813)	Monday, December 25, 2017
(P854)	http://europepmc.org/abstract/MED/18246224

(P921)

(Q101991)

(Q1053470)

(P887)

(P1433)

(Q15755333)

(P248)
(P698)	18246224
(P813)	Monday, December 25, 2017
(P854)	http://europepmc.org/abstract/MED/18246224

(P1476)

"Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy" (language: en)

(P248)
(P698)	18246224
(P813)	Monday, December 25, 2017
(P854)	http://europepmc.org/abstract/MED/18246224

(P2093)

Abdullah A Alghasham

(P1545)	1

(P248)
(P698)	18246224
(P813)	Monday, December 25, 2017
(P854)	http://europepmc.org/abstract/MED/18246224

Youssef A Barakat

(P1545)	2

(P248)
(P698)	18246224
(P813)	Monday, December 25, 2017
(P854)	http://europepmc.org/abstract/MED/18246224

other details

description	scientific article

External Links

(P698)	18246224